Academic positions and Awards:
- Associate Professor, Department of Pathology and Laboratory Medicine, University of British Columbia
- Scientist, Centre for Lymphoid Cancer, Department of Experimental Therapeutics, British Columbia Cancer Agency
- Associate Faculty Member CIHR/MSFHR Bioinformatics Training Program
- Associate Faculty Member Interdisciplinary Oncology Program
- Career Investigator of the Michael Smith Foundation for Health Research (MSFHR)
- Canadian Institutes of Health Research (CIHR) New Investigator Award
Dr. Christian Steidl is an associate professor in the Department of Pathology at the University of British Columbia, and in Experimental Therapeutics at the BC Cancer Agency (BCCA). He holds an MD from the University of Muenster, Germany, and a PhD-equivalent degree from the University of Witten-Herdecke, Germany. Steidl has expertise in clinical malignant hematology, cytogenetics, molecular genetics, next generation sequencing and functional genomics.
Steidl joined the Centre for Lymphoid Cancer at BCCA in 2006. He is currently supervising a translational research laboratory focusing on the pathogenesis of B cell lymphomas. He is most known for his work on biomarkers in Hodgkin lymphoma and the discovery of novel gene fusions in B cell lymphomas. He has authored 41 refereed articles in the field of hematological malignancies and has been an invited speaker at many conferences. He also serves as a member of the Lymphoma Research Foundation’s Panel of Scientific Advisors and the Cancer Research Society’s Medical Expert Committee.
Steidl holds research funding as a principal investigator from the Canadian Institutes of Health Research, the Leukemia and Lymphoma Society of Canada, and the Canadian Hematology Society. He is also co-investigator on a Genome Canada grant to advance personalized treatments of lymphoid cancer patients.
- PhD equivalent, Universitat Witten / Herdecke, Germany. 2003
- MD, University of Muenster Medical School, Germany. 2001